Collectively, these data underscore the multifaceted role of FBXW7 in CRC pathogenesis, prognosis, and therapy response, highlighting its potential as a biomarker for risk assessment and therapeutic targeting. The gene discussed is FBXW7; the disease is colorectal carcinoma.